Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced that dosing is complete in ...
Lake Oswego, OR - January 08, 2026 - PRESSADVANTAGE - At Tersigni Vision, a growing number of patients are asking ...
By integrating concentric multizone optics and Quad-Elevation into a stable scleral platform, patients experience natural, simultaneous focus without sacrificing comfort or clarity.” — Rob Davis, OD ...
The strategy summarises the case for change, identifies road safety targets and outlines an approach to monitoring the ...
Ollin Biosciences, Inc. (Ollin), a clinical-stage biotech advancing best-in-disease therapies for vision-threatening diseases ...
Ollin Biosciences has announced positive topline results from its randomized, head-to-head Phase 1b JADE clinical study ...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, ...
OSN Cornea/External Disease Board Member Eric D. Donnenfeld, MD, and a panel of experts examined a series of unusual ...
Yvonne Felix is watching me. This would not be remarkable for most people I meet with, but Felix is legally blind. She smiles and tells me she can see me taking notes on my computer and every time I ...
Morning Overview on MSN
Researchers think they’ve found a path to restoring human vision
For decades, restoring sight after severe eye damage sat firmly in the realm of science fiction. Now a wave of converging ...
Switching from aflibercept to ranibizumab biosimilars maintains stability in nAMD treatment, offering a cost-effective ...
Veterinary ophthalmologists bridge the gap between clinical surgery and comparative research, ensuring regulatory compliance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback